BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16061637)

  • 1. Lung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiency.
    Zanesi N; Mancini R; Sevignani C; Vecchione A; Kaou M; Valtieri M; Calin GA; Pekarsky Y; Gnarra JR; Croce CM; Huebner K
    Cancer Res; 2005 Aug; 65(15):6576-82. PubMed ID: 16061637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma.
    Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
    Cancer Res; 2003 Jul; 63(13):3724-8. PubMed ID: 12839965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Abnormalities of tumor suppressor genes at chromosome 3p in lung cancer].
    Li L; An Q; Feng X
    Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(7):399-401. PubMed ID: 11798905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fhit and Wwox loss-associated genome instability: A genome caretaker one-two punch.
    Schrock MS; Karras JR; Guggenbiller MJ; Druck T; Batar B; Huebner K
    Adv Biol Regul; 2017 Jan; 63():167-176. PubMed ID: 27773744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma.
    Sükösd F; Kuroda N; Beothe T; Kaur AP; Kovacs G
    Cancer Res; 2003 Jan; 63(2):455-7. PubMed ID: 12543802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.
    Velickovic M; Delahunt B; Störkel S; Grebem SK
    Cancer Res; 2001 Jun; 61(12):4815-9. PubMed ID: 11406557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exome-wide single-base substitutions in tissues and derived cell lines of the constitutive Fhit knockout mouse.
    Paisie CA; Schrock MS; Karras JR; Zhang J; Miuma S; Ouda IM; Waters CE; Saldivar JC; Druck T; Huebner K
    Cancer Sci; 2016 Apr; 107(4):528-35. PubMed ID: 26782170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Loss of heterozygosity of tumor suppressor genes at chromosome 3p in transitional cell carcinoma of urinary bladder].
    Xiao Z; Zhang J; Zheng S; Li C; He Z; Cheng S; Gao Y
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1375-7. PubMed ID: 12509916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fhit, a tumor suppressor protein, induces autophagy via 14-3-3τ in non-small cell lung cancer cells.
    Lee TG; Jeong EH; Kim SY; Kim HR; Kim H; Kim CH
    Oncotarget; 2017 May; 8(19):31923-31937. PubMed ID: 28404875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in squamous cell carcinomas in mouse skin by dietary zinc supplementation.
    Sun J; Shen R; Schrock MS; Liu J; Pan X; Quimby D; Zanesi N; Druck T; Fong LY; Huebner K
    Cancer Med; 2016 Aug; 5(8):2032-42. PubMed ID: 27185213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity.
    Cantor JP; Iliopoulos D; Rao AS; Druck T; Semba S; Han SY; McCorkell KA; Lakshman TV; Collins JE; Wachsberger P; Friedberg JS; Huebner K
    Int J Cancer; 2007 Jan; 120(1):24-31. PubMed ID: 17019711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific oncolytic effect of a new hypoxia-inducible factor-dependent replicative adenovirus on von Hippel-Lindau-defective renal cell carcinomas.
    Cuevas Y; Hernández-Alcoceba R; Aragones J; Naranjo-Suárez S; Castellanos MC; Esteban MA; Martín-Puig S; Landazuri MO; del Peso L
    Cancer Res; 2003 Oct; 63(20):6877-84. PubMed ID: 14583486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hot spots for molecular genetic alterations in lung cancer.
    Pitterle DM; Jolicoeur EM; Bepler G
    In Vivo; 1998; 12(6):643-58. PubMed ID: 9891228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor spectrum in FHIT-deficient mice.
    Zanesi N; Fidanza V; Fong LY; Mancini R; Druck T; Valtieri M; Rüdiger T; McCue PA; Croce CM; Huebner K
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10250-5. PubMed ID: 11517343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
    Waters CE; Saldivar JC; Amin ZA; Schrock MS; Huebner K
    Oncotarget; 2015 Feb; 6(5):3409-19. PubMed ID: 25401976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial deletions including chromosome 3 common eliminated region 1 (C3CER1) prevail in human solid tumors from 10 different tissues.
    Petursdottir TE; Thorsteinsdottir U; Jonasson JG; Moller PH; Huiping C; Bjornsson J; Egilsson V; Imreh S; Ingvarsson S
    Genes Chromosomes Cancer; 2004 Nov; 41(3):232-42. PubMed ID: 15334546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
    Burke L; Khan MA; Freedman AN; Gemma A; Rusin M; Guinee DG; Bennett WP; Caporaso NE; Fleming MV; Travis WD; Colby TV; Trastek V; Pairolero PC; Tazelaar HD; Midthun DE; Liotta LA; Harris CC
    Cancer Res; 1998 Jun; 58(12):2533-6. PubMed ID: 9635574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muir-Torre-like syndrome in Fhit-deficient mice.
    Fong LY; Fidanza V; Zanesi N; Lock LF; Siracusa LD; Mancini R; Siprashvili Z; Ottey M; Martin SE; Druck T; McCue PA; Croce CM; Huebner K
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4742-7. PubMed ID: 10758156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of apoptosis by tumor suppressor FHIT via death receptor signaling pathway in human lung cancer cells.
    Deng WG; Nishizaki M; Fang B; Roth JA; Ji L
    Biochem Biophys Res Commun; 2007 Apr; 355(4):993-9. PubMed ID: 17328863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.